DUBLIN--(BUSINESS WIRE)--The "Fuchs Endothelial Corneal Dystrophy Market - A Global and Regional Analysis: Focus on Treatment Method, End User, and Region - Analysis and Forecast, 2025-2035" report ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

A man from Kent who was losing his eyesight has had his vision restored after a cornea transplant. Julian Pinhey, a professional model maker specialising in very detailed work, had been diagnosed with ...

Optical lattice clocks are emerging timekeeping devices based on tens of thousands of ultracold atoms trapped in an optical lattice (i.e., a grid of laser light). By oscillating between two distinct ...

Superconductors (materials that conduct electricity without resistance) have fascinated physicists for more than a century. While conventional superconductors are well understood, a new class of ...

Lattice Semiconductor shows early signs of revenue rebound, driven by data center strength but offset by weak automotive and industrial markets. LSCC management highlights new opportunities in ...

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...

A number of stocks fell in the afternoon session after reports revealed tech giant Oracle is generating lower-than-expected margins in its cloud business and losing money on Nvidia chip rentals. The ...

Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock is trading higher on Wednesday, with apparently no news to justify the movement. This week, Sarepta will present data from its gene therapy, ...

New Delhi: Zydus Lifesciences Ltd on Monday said it has received final approval from the US health regulator for its generic version of Deflazacort oral suspension used in treating a severe form of ...